NXT Psychedelics
Multiple Psychedelics Companies Come Together In a Watershed Moment For Psilocybin Therapy

On January 5, 2022, Health Canada amended their Food and Drug Regulations to allow practitioners to request access to previously prohibited drugs such as psilocybin, MDMA, and other psychedelic treatments through a new Special Access Program (SAP).

The amendment which reversed a policy from 2013 that prohibited special access to restricted drugs was seen as a watershed moment for the psychedelics industry.

Only months later on March 21, 2022, Dr. Valorie Masuda MD received authorization to treat six patients experiencing end-of-life distress with psilocybin and psychotherapy in what is the first known case of psilocybin being accessed through Canada’s SAP.

Learn More

Share this post